ERNEST SMITH: Open Payments
NPI 1356519706 · JAMESTOWN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,318 in 219 payments from 23 companies in 2025. Trend: 2023 $76 · 2024 $2,665 · 2025 $4,318
Food & beverage: $4,125Education: $175Travel & lodging: $18
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 65 | $1,167 |
| Vanda Pharmaceuticals Inc. | 24 | $443 |
| Teva Pharmaceuticals USA, Inc. | 23 | $429 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $423 |
| Novo Nordisk Inc | 9 | $299 |
| Axsome Therapeutics, Inc. | 17 | $276 |
| Alkermes, Inc. | 18 | $271 |
| Forte Bio-Pharma LLC | 9 | $209 |
| Lilly USA, LLC | 11 | $188 |
| Neurocrine BioSciences, Inc. | 6 | $139 |
Products named: QULIPTA, VRAYLAR, CAPLYTA, FANAPT, HETLIOZ, ARISTADA, PROLATE, Wegovy.
Industry payments across NC — which companies pay providers there.
